|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/30 | |||
| A61P 35/00 | |||
| C07K 16/32 | |||
| A61K 39/00 |
| (11) | Number of the document | 2237792 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08865503.0 |
| Date of filing the European patent application | 2008-12-23 | |
| (97) | Date of publication of the European application | 2010-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/013998 |
| Date | 2008-12-23 |
| (87) | Number | WO 2009/082485 |
| Date | 2009-07-02 |
| (30) | Number | Date | Country code |
| 16763 P | 2007-12-26 | US |
| (72) |
ZAUDERER, Maurice, US
EVANS, Elizabeth, E., US
|
| (73) |
Vaccinex, Inc.,
1895 Mt. Hope Avenue, Rochester, NY 14620,
US
|
| (54) | ANTI-C35 ANTIBODY COMBINATION THERAPIES AND METHODS |
| ANTI-C35 ANTIBODY COMBINATION THERAPIES AND METHODS |